Dried Blood Spots

The DBS blood collection platform is rapidly becoming an important basis for quantitative analysis of biomarkers. Such self-monitoring and self-sensing, which combines wearable sensors (EEG, ECG) collection of biosamples in a non or minimal invasive way  and wearable computing, is also known as lifelogging.
We develop on request assays for most biomarkers. The degree of assay validation is agreed with sponsor.  There are many options for reporting.

For all our applications, please visit the site APPLICATIONS.

AM-305Quantification of amino acids in dried blood spots using GC-MS
 
 
AM-296Quantification of Adiponectin in Dried Blood Spots using ELISA
 
 
AM-265Quantification of Lipoprotein A (APOA) in Dried Blood Spots using ELISA
 
 
AM-263Quantification of Leptin in Dried Blood Spots using ELISA
 
 
AM-250Quantification of triglycerides in Dried Blood Spots using ELISA
 
 
AM-248Quantitation of IGF-1 in Dried Blood Spots using ELISA
 
 
 AM-156Quantification of Vitamin K1 in dried blood spots by LC-FLD
 
 
 AM-155Quantification of Vitamin E in dried blood spots by LC-FLD
 
 
 AM-145Quantitative determination of Retinol in dried blood spots (DBS) from humans by LC-MS
 
 
 AM-113Quantitative determination of caffeine and paraxanthin in dried blood spots (DBS) using LC-UV
 
 
 AM-094Quantification of transferrin receptor (TfR) in dried blood spots by EIA
 
 
 AM-068Quantification of  vitamin A in dried blood spots using LC/MS with APCI detection
 
 
 AM-038Carotenoids in dried Blood spots by HPLC-UV
 
 
 AM-037Quantification of 25-OH-Vitamin D3 in Dried Blood Spots by HPLC-MS/MS
 
 
 AM-036Quantification of glucose in Dried Blood Spots by derivatisation and spectrophotometry
 
 
 AM-035Quantification of total cholesterol in Dried Blood Spots by HPLC-UV
 
 
AM-009Omega3-Index in dried blood spots (DBS)